Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|62|12|3569-3573

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3569-3573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases

By Stamp Lisa K   Roberts Rebecca L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1449-1463

Future Medicine

Access to resources Recommend Favorite

Optimising treatment after acute MI in patients with diabetes

By  

Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Assessment of Thyroid Disorders and Autoimmunity in Patients with Rheumatic Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 3, 2014-09 ,pp. : 182-186

Bentham Science Publishers

Access to resources Recommend Favorite

Glucocorticoids in Patients with Rheumatic Diseases: Friends or Enemies of Bone?

By  

Current Medicinal Chemistry, Vol. 22, Iss. 5, 2015-02 ,pp. : 596-603

Bentham Science Publishers

Access to resources Recommend Favorite

Infections in Patients with Rheumatic Diseases Treated with TNF Antagonists

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1418-1425

Bentham Science Publishers

Access to resources Recommend Favorite